Logotype for ADENTRA Inc

ADENTRA (ADEN) Q2 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for ADENTRA Inc

Q2 2025 earnings summary

23 Nov, 2025

Executive summary

  • Q2 sales reached $597.1 million, up 8.7% year-over-year, driven by the Wolf/Woolf Distributing acquisition and steady organic sales.

  • Adjusted EBITDA rose 12% to $54.3 million, with adjusted EPS at $0.88 and basic EPS at $0.89.

  • Gross margin improved to 21.8%, with operating expenses down 3.9%.

  • Cash flow from operations was $33.9 million, supporting debt reduction and $11.2 million in shareholder returns.

  • The company remains resilient amid soft construction markets, focusing on disciplined execution and long-term EPS growth.

Financial highlights

  • US sales grew 9.3% to $551.6 million, mainly from the Wolf/Woolf acquisition; Canadian sales rose 2.8% to C$63.1 million.

  • Gross profit was $130.1 million (up 9.1%), with gross margin at 21.8%.

  • Q2 net income was $22.1 million, up 29.9% year-over-year; adjusted net income fell 6.7% to $21.9 million due to higher interest and tax expenses.

  • Operating cash flow was $33.9 million, up from $23.8 million in Q2 last year.

  • Six-month sales increased 5.1% to $1.14 billion, with gross margin up 4.0% to $247.1 million.

Outlook and guidance

  • Inventory is expected to decline in the second half, improving leverage to the mid-teens range by year-end.

  • July average daily sales tracked about 4% below Q2 levels, with some improvement in the latter half of the month.

  • Long-term fundamentals in residential construction remain positive, with focus on disciplined execution and adaptability.

  • Strategic priorities include driving double-digit returns and acquisitive growth through platform efficiency, organic initiatives, and targeted M&A.

  • Strong cash generation expected in H2, with priorities on reducing leverage and strengthening the balance sheet.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more